2008
DOI: 10.1016/j.pupt.2008.09.004
|View full text |Cite
|
Sign up to set email alerts
|

A role for MC3R in modulating lung inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
56
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 58 publications
(62 citation statements)
references
References 36 publications
3
56
3
Order By: Relevance
“…Alone, SHU9119 caused a modest inhibition of IL-1 but had no effect on TNF--induced IL-6 or IL-8 production, consistent with its dual agonist/antagonist nature. Remarkably, while SHU9119 was unable to block the effect of -MSH, it abridged the anti-inflammatory activity of D[TRP] 8 --MSH, thus suggesting a potential role for MC 3 in chondroprotection, which agrees with previous studies reporting MC 3 agonist activity of this peptide [51,76,79]. Moreover, at higher concentrations of -MSH, the presence of SHU9119 synergistically reduced IL-6 release, thereby signifying that SHU9119 may be concerting efforts with -MSH via either activation of MC 1 and/or MC 5 .…”
supporting
confidence: 91%
See 1 more Smart Citation
“…Alone, SHU9119 caused a modest inhibition of IL-1 but had no effect on TNF--induced IL-6 or IL-8 production, consistent with its dual agonist/antagonist nature. Remarkably, while SHU9119 was unable to block the effect of -MSH, it abridged the anti-inflammatory activity of D[TRP] 8 --MSH, thus suggesting a potential role for MC 3 in chondroprotection, which agrees with previous studies reporting MC 3 agonist activity of this peptide [51,76,79]. Moreover, at higher concentrations of -MSH, the presence of SHU9119 synergistically reduced IL-6 release, thereby signifying that SHU9119 may be concerting efforts with -MSH via either activation of MC 1 and/or MC 5 .…”
supporting
confidence: 91%
“…reduce cytokine relase is well documented both in vitro [63,64] and in vivo models of inflammation [60][61][62]76], this is the first time their protective properties have been studied in an in situ model of mechanically-induced cartilage injury, and the first indication that targeting the melanocortin receptor system for the development of potential treatment of mechanical/sports injuries and trauma is a viable option.…”
Section: Discussionmentioning
confidence: 91%
“…It is also expressed in several peripheral tissues, including the placenta, gut, heart, kidney, and peritoneal macrophages ( Chhajlani 1996 ; Gantz et al 1993 ; Getting et al 2003 ; Ni et al 2006 ). Based on its wide distribution, the MC3R has been shown to be involved in regulating cardiovascular function ( Mioni et al 2003 ; Versteeg et al 1998 ), natriuresis ( Chandramohan et al 2009 ; Ni et al 2006 ), and inflammation ( Catania et al 2004 ; Getting et al 2006 ; Getting et al 2008 ).…”
Section: Introductionmentioning
confidence: 99%
“…Getting et al reported the anti-inflammatory effects of the analogue D-Trp 8 -␥-MSH in a model of crystal-induced inflammation 7 and, more recently, in an model of allergic inflammation. 8 The same compound was also active in a model of ischemia-reperfusion injury 9 and in inflammatory arthritis. 10 The ␣-MSH-derived C-terminal tripeptide KPV is anti-inflammatory in crystal-induced peritonitis 11 and in two models of inflammatory bowel disease.…”
mentioning
confidence: 99%